The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Risk factors for age-related macular degeneration
Abstract
Objective To assess the prevalence and potential risk factors for late age-related macular degeneration (AMD) in three racially similar populations from North America, Europe, and AUSTRALIA:Design Combined analysis of population-based eye disease prevalence data.Participants There were 14,752 participants with gradable photographs from the Beaver Dam Eye Study (n = 4756), Rotterdam Study (n = 6411), and Blue Mountains Eye Study (n = 3585).Main outcome measures AMD diagnosis was made from masked grading of stereo macular photographs. Final classification of AMD cases was agreed by consensus between study investigators.Results AMD prevalence was strongly age related. Overall, AMD was present in 0.2% of the combined population aged 55 to 64 years, rising to 13% of the population older than 85 years. Prevalence of neovascular AMD (NV) increased from 0.17% among subjects aged 55 to 64 years to 5.8% for those older than 85 years. Prevalence of pure geographic atrophy (GA) increased from 0.04% to 4.2% for these age groups. There were no significant gender differences in the prevalence of NV or GA. Subjects in the Rotterdam population had a significantly lower age-adjusted and smoking-adjusted risk of NV than subjects in the Beaver Dam and Blue Mountains populations. Apart from age, tobacco smoking was the only risk factor consistently associated with any form of AMD in all sites separately and in pooled analyses over the three sites.Conclusions These combined data from racially similar communities across three continents provide strong and consistent evidence that tobacco smoking is the principal known preventable exposure associated with any form of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In total, data from 18 prospective, cross-sectional studies and 8 case control studies [12,24-26,28,30,31,33-47,49-54,57-73] were included in the final analysis, contributing a sample of some 94,058 patients (ranging from 261 to 22,071) including 3,178 (ranging from 8 to 776) late AMD cases.”
From Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis (2010) · cites this paper as [25]
In the citing paper
“Age is the strongest risk factor associated with the development of AMD (3, 112, 140) (Figure 3).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [140]
In the citing paper
“The pooled data from two population-based studies reveal an estimated prevalence of advanced AMD of ~0.2% in ages 55 to 64, increasing to 13% in those older than 85 years (140).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [140]
In the citing paper
“Female sex may be a risk factor in individuals aged over 75 years,16 with the relative risk for neovascular age-related macular degeneration in women possibly as much as twice that observed in age-matched men.”
From Age-related macular degeneration (2008) · cites this paper as [16]
In the citing paper
“These three large population-based studies have found that the incidence of advanced age-related macular degeneration increases with age, as does the development of large drusen and pigmentary changes.”
From Age-related macular degeneration (2008) · cites this paper as [16]
In the citing paper
“Data pooled from three population-based studies—the Beaver Dam Eye Study, the Rotterdam Study, and the Blue Mountains Eye Study—have estimated the prevalence of advanced age-related macular degeneration to be 0·2% in those aged 55–64 years, increasing to 13% in those older than 85 years.16”
From Age-related macular degeneration (2008) · cites this paper as [16]
Citations
Cites
Bird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Self-citationPrevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845
Self-citationKlein, R., Klein, R., Moss, S. E., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32011-1 · Cited by 1,382
Self-citationLeibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., KINI, M. M., Kahn, H. A., Nickerson, R. J., Pool, J., Colton, T., Ganley, J. P., et al. (1980) · PubMed · Cited by 1,250
The Wisconsin Age-related Maculopathy Grading System
Klein, R., Davis, M. D., Magli, Y. L., Segał, P., Klein, R., & Hubbard, L. D. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32186-9 · Cited by 1,188
Self-citationThe Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, R., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,154
Self-citationPrevalence of age-related maculopathy in Australia
Mitchell, P., Smith, W., Attebo, K., & Wang, J. J. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30846-9 · Cited by 1,062
Self-citationThe Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Drusen and Disciform Macular Detachment and Degeneration
Gass, J. D. M. (1973) · Archives of Ophthalmology · doi:10.1001/archopht.1973.01000050208006 · Cited by 593
Senile macular degeneration: a case-control study
HYMAN, L. G., LILIENFELD, A. M., FERRIS, F. L., & FINE, S. L. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113629 · Cited by 587
Cited by
Sorted by citations
Items 401–500 of 1,000
Statins for age-related macular degeneration
Gehlbach, P. L., Li, T., & Hatef, E. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006927.pub5 · Cited by 36
Neuroprotective Effects of Nonfeminizing Estrogens in Retinal Photoreceptor Neurons
Nixon, E., & Simpkins, J. W. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9517 · Cited by 36
The Application of Genetic Risk Scores in Age-Related Macular Degeneration: A Review
Bailey, J. N. C., Hoffman, J., Sardell, R. J., Scott, W. K., Pericak‐Vance, M. A., & Haines, J. L. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030031 · Cited by 36
The Need for Routine Eye Examinations
Taylor, H. R., Vu, H. T., McCarty, C. A., & Keeffe, J. E. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1198 · Cited by 36
Nikolopoulou, E., Lorusso, M., Ferrari, L. M., Cicinelli, M. V., Bandello, F. M., Querques, G., & Ferrari, T. M. (2018) · BioMed Research International · doi:10.1155/2018/6724818 · Cited by 35
Epigenetics in Age-related Macular Degeneration (AMD)
Desmettre, T. J. (2018) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2018.09.001 · Cited by 35
Freeman, W. R., Kozak, I., Yuson, R. M. S., Nigam, N., Cheng, L., & Mojana, F. (2011) · Retina · doi:10.1097/iae.0b013e31821987a4 · Cited by 35
LXIII Edward Jackson Memorial Lecture: Eye Care: Dollars and Sense
Taylor, H. R. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.10.003 · Cited by 35
Shahbazi, S., Mokhtari‐Dizaji, M., & Mansori, M. R. (2011) · Ultrasonics · doi:10.1016/j.ultras.2011.08.004 · Cited by 35
Treatment Patterns and Health Care Costs for Age-Related Macular Degeneration in Japan
Kume, A., Ohshiro, T., Sakurada, Y., Kikushima, W., Yoneyama, S., & Kashiwagi, K. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.042 · Cited by 34
Kim, E., Kim, H., Vijayakumar, A., Kwon, O., & Chang, N. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0301-2 · Cited by 34
Bae, K., Kim, H. J., Shin, Y. K., & Kang, S. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-55871-8 · Cited by 34
Motschi, A. R., Roberts, P. K., Desissaire, S., Schranz, M. W., Schwarzhans, F., Bogunović, H., Pircher, M., & Hitzenberger, C. K. F. (2021) · Biomedical Optics Express · doi:10.1364/boe.426650 · Cited by 34
Lombardo, M., Serrao, S., & Lombardo, G. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.887104 · Cited by 34
An update on photodynamic therapy in age-related macular degeneration
Rechtman, E., Ciulla, T. A., Criswell, M. H., Pollack, A., & Harris, A. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.7.931 · Cited by 34
Kelly, S. P., Thornton, J., Lyratzopoulos, G., Edwards, R., & Mitchell, P. (2004) · BMJ · doi:10.1136/bmj.328.7439.537 · Cited by 34
Self-citationStatins for age-related macular degeneration
Gehlbach, P. L., Li, T., & Hatef, E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006927.pub4 · Cited by 34
Voloboueva, L. A., Killilea, D. W., Atamna, H., & Ames, B. N. (2007) · The FASEB Journal · doi:10.1096/fj.07-8396com · Cited by 33
Fixation Control before and after Treatment for Neovascular Age-Related Macular Degeneration
González, E. G., Tarita‐Nistor, L., Mandelcorn, E. D., Mandelcorn, M. S., & Steinbach, M. J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-7026 · Cited by 33
Characteristics of Neovascular Age-Related Macular Degeneration in Brazilian Patients
Pereira, F. B., Veloso, C. E. D. R., Kokame, G. T., & Nehemy, M. B. (2015) · Ophthalmologica · doi:10.1159/000439359 · Cited by 33
Pereira‐Figueiredo, D., Nascimento, A., Cunha-Rodrigues, M. C., Brito, R., & Calaza, K. D. C. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01077-4 · Cited by 35
Association between systemic arterial stiffness and age-related macular degeneration
Sato, E., Feke, G. T., Appelbaum, E. Y., Menke, M. N., Trempe, C. L., & McMeel, J. W. (2006) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0201-6 · Cited by 33
Droz, I., Mantel, I., Ambresin, A., Faouzi, M., Schorderet, D. F., & Munier, F. L. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.127811 · Cited by 35
Role of flavonoids in age-related macular degeneration
Sun, M., Yu, T., Zhao, J., Zhu, X., Xin, W., Zhang, F., & Zhang, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114259 · Cited by 34
Moeini, H. A. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.066241 · Cited by 32
Treatment for neovascular age related macular degeneration: The state of the art
Eandi, C. M., Alovisi, C., de Sanctis, U., & Grignolo, F. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.002 · Cited by 33
Downie, L. E., & Keller, P. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124533 · Cited by 31
Xu, L., Xie, X., Wang, Y. X., & Jonas, J. B. (2008) · Eye · doi:10.1038/sj.eye.6703104 · Cited by 31
Holographic display system for restoration of sight to the blind
Goetz, G. A., Mandel, Y., Manivanh, R. V., Palanker, D., & Čižmár, T. (2013) · Journal of Neural Engineering · doi:10.1088/1741-2560/10/5/056021 · Cited by 31
Javadzadeh, A., Ghorbanihaghjo, A., Bahreini, E., Rashtchizadeh, N., Argani, H., & Alizadeh, S. (2010) · PubMed Central · Cited by 31
Biasella, F., Plößl, K., Karl, C., Weber, B. H. F., & Friedrich, U. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.14.2 · Cited by 30
Patterns and Costs Associated With Progression of Age-Related Macular Degeneration
Schmier, J. K., COVERT, D. W., & Lau, E. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.04.017 · Cited by 30
Candidate gene study of macular response to supplemental lutein and zeaxanthin
Yonova‐Doing, E., Hysi, P. G., Venturini, C., Williams, K. M., Nag, A., Beatty, S., Liew, S. H. M., Gilbert, C. E., & Hammond, C. J. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.07.020 · Cited by 30
Age-Related Macular Degeneration and the Other Double Helix The Cogan Lecture
Ambati, J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7328 · Cited by 30
Estimated Prevalence and Risk Factor for Age-related Maculopathy
Roh, M., Kim, J. H., Byeon, S. H., Koh, H. J., Lee, S. C., & Kwon, O. W. (2008) · Yonsei Medical Journal · doi:10.3349/ymj.2008.49.6.931 · Cited by 31
Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration
Chen, J., Connor, K. M., & Smith, L. E. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33513 · Cited by 29
Lee, S. J., Kim, N. R., & Chin, H. S. (2010) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2010.02316.x · Cited by 30
Injectable intraocular telescope: Pilot study
Qureshi, M. A., Robbie, S. J., Tabernero, J., & Artal, P. (2015) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2015.03.021 · Cited by 29
May, A., Su, F., Dinh, B., Ehlen, R., Tran, C., Adivikolanu, H., & Shaw, P. X. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108605 · Cited by 31
Factors determining age-related macular degeneration: a current view
Liutkevičienė, R., Lesauskaitė, V., Ašmonienė, V., Žaliūnienė, D., & Jašinskas, V. (2010) · Medicina · doi:10.3390/medicina46020013 · Cited by 29
Neuronal degradation in mouse retina after a transient ischemia and protective effect of hypothermia
Wang, X., Niwa, M., Hara, A., Matsuno, H., Kawase, K., Kozawa, O., Mori, H., & Uematsu, T. (2002) · Neurological Research · doi:10.1179/016164102101200663 · Cited by 29
Chheda, L. V., Ferketich, A. K., Carroll, C. P., Moyer, P. D., Kurz, D. E., & Kurz, P. A. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.08.003 · Cited by 29
Gupta, V., Agarwal, A. K., & Aggarwal, K. (2016) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.173133 · Cited by 29
Fields, M. A., Bowrey, H. E., Gong, J., Moreira, E. F., Cai, H., & Priore, L. V. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177763 · Cited by 29
Lüdtke, L., Jürgens, C., Ittermann, T., Völzke, H., & Tost, F. (2019) · Medical Science Monitor · doi:10.12659/msm.915493 · Cited by 28
Hutnik, C. M. L., Kagan, D. B., & Liu, H. (2012) · Clinical ophthalmology · doi:10.2147/opth.s35139 · Cited by 28
Nonyane, B. A. S., Nitsch, D., Whittaker, J. C., Sofat, R., Smeeth, L. L., Chakravarthy, U., & FLETCHER, A. E. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4228 · Cited by 28
Lechanteur, Y. T. E., van de Camp, P., Smailhodzic, D., van de Ven, J. P. H., Buitendijk, G. H. S., Klaver, C. C. W., Groenewoud, J. M. M., den Hollander, A. I., Hoyng, C. B., & Klevering, B. J. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.18 · Cited by 28
Self-citationDo Nutritional Supplements Have a Role in Age Macular Degeneration Prevention?
Pinazo-Duran, M. D., Gómez‐Ulla, F., Arias, L., Araiz, J., Casaroli-Marano, R. P., Gallego‐Pinazo, R., García‐Medina, J. J., Gálvez, M. I. L., Manzanas, L., Salas, A., et al. (2014) · Journal of Ophthalmology · doi:10.1155/2014/901686 · Cited by 28
Joachim, N., Mitchell, P., Younan, C., Burlutsky, G., Cheng, C., Cheung, C. M. G., Zheng, Y., Moffitt, M., Wong, T. Y., & Wang, J. J. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14476 · Cited by 28
Self-citationRISK FACTORS FOR SECOND EYE PROGRESSION TO ADVANCED AGE-RELATED MACULAR DEGENERATION
Submacular Surgery Trials Research Group (2009) · Retina · doi:10.1097/iae.0b013e3181b1baeb · Cited by 28
Karnon, J. D., Czoski‐Murray, C., Smith, K. J., Brand, C., Chakravarthy, U., Davis, S., Bansback, N. J., Beverley, C., Bird, A. C., Harding, S. P., et al. (2008) · Health Technology Assessment · doi:10.3310/hta12270 · Cited by 28
Kim, S. J., Lee, S., Kim, N. R., & Chin, H. S. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.01.005 · Cited by 27
Tamura, H., Tsujikawa, A., Yamashiro, K., Akagi-Kurashige, Y., Nakata, I., Nakanishi, H., Hayashi, H., Ooto, S., Otani, A., & Yoshimura, N. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.042 · Cited by 27
Genetic epidemiology with a Capital E, ten years after
Khoury, M. J., GWINN, M. L., Clyne, M., & Yu, W. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20634 · Cited by 27
Rudolf, M., Sefat, A. M. M., Miura, Y., Tura, A., Raasch, W., Ranjbar, M., Grisanti, S., Aherrahrou, Z., Wägner, A., Messinger, J. D., et al. (2017) · Current Eye Research · doi:10.1080/02713683.2017.1370118 · Cited by 27
Ogasawara, M., Koizumi, H., Yamamoto, A., Itagaki, K., Saito, M., Maruko, I., Okada, A. A., Iida, T., & Sekiryu, T. (2018) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-018-0605-6 · Cited by 27
Bikbov, M. M., Zainullin, R. M., Риксович, Г. Т., Kazakbaeva, G. M., Rakhimova, E. M., Rusakova, I. A., Bolshakova, N. I., Safiullina, K. R., Yakupova, D. F., Uzianbaeva, Y. V., et al. (2019) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2019.10.004 · Cited by 27
Age-related Macular Degeneration (AMD): A Review on its Epidemiology and Risk Factors
Salimiaghdam, N., Riazi-Esfahani, M., Fukuhara, P. S., Schneider, K., & Kenney, M. C. (2019) · The Open Ophthalmology Journal · doi:10.2174/1874364101913010090 · Cited by 30
Electronic Retinal ProsthesesPreprint
Palanker, D. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1016/b978-0-12-809324-5.24123-0 · Cited by 32
Screening for Impaired Visual Acuity in Older Adults
US Preventive Services Task Force, Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M. D., Chelmow, D. P., Coker, T. R., Davis, E. M., Donahue, K. E., Epling, J. W., et al. (2022) · JAMA · doi:10.1001/jama.2022.7015 · Cited by 30
Yu, A. L., Lorenz, R. L., Haritoglou, C., Kampik, A., & Welge‐Lüßen, U. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.10.028 · Cited by 27
Ying, G., & Maguire, M. G. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.06.030 · Cited by 27
Cachulo, M. L., Laíns, I., Lobo, C. L., Figueira, J., Ribeiro, L., Marques, J. P., Costa, J. C., Vieira, A., Rodrigues, J., Alves, D., et al. (2016) · Acta Ophthalmologica · doi:10.1111/aos.12950 · Cited by 27
Sub-Airy Confocal Adaptive Optics Scanning Ophthalmoscopy
Sredar, N., Fagbemi, O. E., & Dubra, A. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.2.17 · Cited by 27
Deletion of Efemp1 Is Protective Against the Development of Sub-RPE Deposits in Mouse Eyes
Stanton, J. B., Marmorstein, A. D., Zhang, Y., & Marmorstein, L. Y. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20955 · Cited by 27
Fenton, C., & Perry, C. M. (2006) · Drugs & Aging · doi:10.2165/00002512-200623050-00006 · Cited by 27
Feigl, B., Lovie‐Kitchin, J. E., & Brown, B. H. (2005) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2005.tb06714.x · Cited by 27
Postel, E. A., Agarwal, A., Schmidt, S., Fan, Y.-T. R., Scott, W. K., Gilbert, J. R., Haines, J. L., & Pericak‐Vance, M. A. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.12.029 · Cited by 27
Tong, N., Jin, R., Zhou, Z., & Wu, X. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00137 · Cited by 26
Familial aggregation of age-related macular degeneration in the Utah population
Luo, L., Harmon, J., Yang, X., Chen, H., Patel, S., Mineau, G., Yang, Z., Constantine, R., Buehler, J., Kaminoh, Y., et al. (2008) · Vision Research · doi:10.1016/j.visres.2007.11.013 · Cited by 26
Robman, L. D. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s2748 · Cited by 26
Association of Anti-VEGF Injections with Progression of Geographic Atrophy
Enslow, R., Bhuvanagiri, S., Vegunta, S., Cutler, B., Neff, M., & Stagg, B. C. (2016) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s38863 · Cited by 26
Liu, Y., Wang, C., & Su, G. (2019) · Journal of Ophthalmology · doi:10.1155/2019/5743109 · Cited by 24
Necroptosis and Neuroinflammation in Retinal Degeneration
Tao, Y., Murakami, Y., Vavvas, D. G., & Sonoda, K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.911430 · Cited by 27
Influence of macular pigment and melanin on incident early AMD in a white population
Kanis, M. J., Berendschot, T. T. J. M., & Norren, D. V. (2006) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-006-0478-0 · Cited by 26
Bonilha, V. L., Shadrach, K. G., Rayborn, M. E., Li, Y., Pauer, G. J. T., Hagstrom, S. A., Bhattacharya, S. K., & Hollyfield, J. G. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.03.017 · Cited by 26
Andersen, N., Rosenberg, T., la Cour, M., Kiilgaard, J. F., Prause, J. U., ALSBIRK, P. H., Borch‐Johnsen, K., Pető, T., Carstensen, B., & Bird, A. C. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.12.013 · Cited by 26
Marback, R. F., Júnior, O. D. O. M., Morais, F. B., & Takahashi, W. Y. (2007) · Clinics · doi:10.1590/s1807-59322007000500007 · Cited by 26
Formal and informal care utilisation amongst elderly persons with visual impairment
Ke, K., Montgomery, A.-M., Stevenson, M., O’Neill, C., & Chakravarthy, U. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.113142 · Cited by 26
Winkler, T. W., Brandl, C., Graßmann, F., Gorski, M., Stark, K. J., Loss, J., Weber, B. H. F., & Heid, I. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194321 · Cited by 26
Genetics of age-related macular degeneration
KLEIN, M., & Francis, P. J. (2003) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(03)00063-4 · Cited by 26
Ke, K. M. (2010) · The European Journal of Health Economics · doi:10.1007/s10198-009-0207-9 · Cited by 25
Intraocular vision-improving devices in age-related macular degeneration
Grzybowski, A. E., Wang, J., Mao, F., Wang, D., & Wang, N. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-5851 · Cited by 25
Self-citationAssociation of Metformin With the Development of Age-Related Macular Degeneration
Domalpally, A., Whittier, S. A., Pan, Q., Dabelea, D., Darwin, C. H., Knowler, W. C., Lee, C. G., Luchsinger, J. A., White, N. H., Chew, E. Y., et al. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.5567 · Cited by 25
Buch, H. (2005) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2005.thesis.x · Cited by 25
Risk factors for exudative age-related macular degeneration in a large French case–control study
Zerbib, J., Delcourt, C., Puche, N., Querques, G., Cohen, S. Y., Sahel, J., Korobelnik, J., Goff, M. L., & Souied, E. H. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2537-7 · Cited by 28
Prevalence of age-related macular degeneration among the elderly.
Rasoulinejad, S. A., Zarghami, A., Hosseini, S. R., Rajaee, N., Rasoulinejad, S. E., & Mikaniki, E. (2015) · PubMed Central · Cited by 25
Kabanarou, S. A., Xirou, T., Mangouritsas, G., Garnavou‐Xirou, C., Boutouri, E., Gkizis, I., & Chatziralli, I. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s135364 · Cited by 25
Eng, V., Rayess, N., Nguyen, H. V., & Leng, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232353 · Cited by 28
Characteristics of pachychoroid neovasculopathy
Tagawa, M., Ooto, S., Yamashiro, K., Tamura, H., Oishi, A., Miyata, M., Hata, M., Yoshikawa, M., Yoshimura, N., & Tsujikawa, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-73303-w · Cited by 25
Epidemiology of Age-Related Maculopathy: A Review
Klaver, C. C. W., van Leeuwen, R., Vingerling, J. R., & de Jong, P. T. V. M. (2004) · Springer eBooks · doi:10.1007/978-3-662-05199-3_1 · Cited by 25
Self-citationEFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration
Cheng, L., Chen, C., Guo, W., Liu, K., Zhao, Q., Lü, P., Yu, F., & Xu, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.547436 · Cited by 24
Age-Related Macular Degeneration
Fleckenstein, M., & Holz, F. G. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_12 · Cited by 24
Ocular hazards of blue-light therapy in dermatology
Walker, D. P., Vollmer-Snarr, H. R., & Eberting, C. L. D. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.040 · Cited by 24
Lutein and Factor D: Two intriguing players in the field of age-related macular degeneration
Tian, Y., Kijlstra, A., Webers, C. A. B., & Berendschot, T. T. J. M. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.01.019 · Cited by 24
Pluripotent stem cells and their utility in treating photoreceptor degenerations
Aghaizu, N. D., Kruczek, K., Gonzalez-Cordero, A., Ali, R. R., & Pearson, R. A. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2017.01.001 · Cited by 25
An inducible form of Nrf2 confers enhanced protection against acute oxidative stresses in RPE cells
Vu, K. T., & Hulleman, J. D. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.08.001 · Cited by 24
Systemic inflammation and eye diseases. The Beijing Eye Study
Jonas, J. B., Wei, W. B., Xu, L., & Wang, Y. X. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204263 · Cited by 26
Iris color and associated pathological ocular complications: a review of epidemiologic studies.
Sun, H., Lin, Y. H., & Pan, C. (2014) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2014.05.25 · Cited by 24
Metadata
- Authors
- Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M.
- Affiliations
- Australian National University (AU)
- Erasmus University Rotterdam (NL)
- The University of Sydney (AU)
- University of Wisconsin–Madison (US)
- Corresponding author
- Mitchell, Paul
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 108
- Issue
- 4
- Pages
- 697-704
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W1543801259
- Cited by
- 1,071
- References
- 43
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 43 · 2023: 33 · 2022: 44 · 2021: 51 · 2020: 30 · 2019: 28 · 2018: 33 · 2017: 43 · 2016: 43 · 2015: 46 · 2014: 70 · 2013: 52 · 2012: 60
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, neovascular AMD, geographic atrophy, prevalence, risk factors, smoking, age, gender differences, Beaver Dam Eye Study, Rotterdam Study, Blue Mountains Eye Study, cross-population comparison
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Macular Degeneration, Male, Middle Aged, Netherlands, New South Wales, Risk Factors, Smoking, Wisconsin, Prevalence, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review